- Home
- PZC vs ZOM Comparison
PZC vs ZOM Comparison
Compare PZC & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZC
- ZOM
- Stock Information
- Founded
- PZC 2002
- ZOM 2015
- Country
- PZC United States
- ZOM United States
- Employees
- PZC N/A
- ZOM N/A
- Industry
- PZC Investment Managers
- ZOM Biotechnology: Pharmaceutical Preparations
- Sector
- PZC Finance
- ZOM Health Care
- Exchange
- PZC Nasdaq
- ZOM Nasdaq
- Market Cap
- PZC 168.0M
- ZOM 135.9M
- IPO Year
- PZC N/A
- ZOM N/A
- Fundamental
- Price
- PZC $6.92
- ZOM $0.12
- Analyst Decision
- PZC
- ZOM
- Analyst Count
- PZC 0
- ZOM 0
- Target Price
- PZC N/A
- ZOM N/A
- AVG Volume (30 Days)
- PZC 48.2K
- ZOM 4.6M
- Earning Date
- PZC 01-01-0001
- ZOM 11-07-2024
- Dividend Yield
- PZC 4.68%
- ZOM N/A
- EPS Growth
- PZC N/A
- ZOM N/A
- EPS
- PZC N/A
- ZOM N/A
- Revenue
- PZC N/A
- ZOM $26,727,000.00
- Revenue This Year
- PZC N/A
- ZOM $36.75
- Revenue Next Year
- PZC N/A
- ZOM $14.92
- P/E Ratio
- PZC N/A
- ZOM N/A
- Revenue Growth
- PZC N/A
- ZOM 11.33
- 52 Week Low
- PZC $6.30
- ZOM $0.12
- 52 Week High
- PZC $8.20
- ZOM $0.23
- Technical
- Relative Strength Index (RSI)
- PZC 29.19
- ZOM 40.37
- Support Level
- PZC $6.91
- ZOM $0.12
- Resistance Level
- PZC $7.26
- ZOM $0.13
- Average True Range (ATR)
- PZC 0.07
- ZOM 0.00
- MACD
- PZC -0.02
- ZOM -0.00
- Stochastic Oscillator
- PZC 5.71
- ZOM 8.67
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.